Pharmacokinetics and tissue distribution of a novel PDE5 inhibitor, SK-3530, in rats
- 1 August 2007
- journal article
- Published by Springer Science and Business Media LLC in Acta Pharmacologica Sinica
- Vol. 28 (8), 1247-1253
- https://doi.org/10.1111/j.1745-7254.2007.00611.x
Abstract
APS (Acta Pharmacologica Sinica), the top pharmacology research journal based in China, publishes original articles and reviews on all aspects of pharmacology and the related life sciencesKeywords
This publication has 12 references indexed in Scilit:
- Synthesis of 5-ethyl-2-{5-[4-(2-hydroxyethyl)piperazin-1-ylsulfonyl]-2-n-propoxyphenyl}-7-n-propyl-3,5-dihydro-4H-pyrrolo[3,2-d]-[2-14C]pyrimidin-4-one·2 HCl (14C-SK3530·2 HCl)Journal of Labelled Compounds and Radiopharmaceuticals, 2006
- Pharmacokinetics of sildenafil after intravenous and oral administration in rats: Hepatic and intestinal first-pass effectsInternational Journal of Pharmaceutics, 2006
- Cardiovascular Effects of the 3 Phosphodiesterase-5 Inhibitors Approved for the Treatment of Erectile DysfunctionCirculation, 2004
- Plasma Levels of cAMP, cGMP and CGRP in Sildenafil-Induced HeadacheCephalalgia, 2004
- Overview of phosphodiesterase 5 inhibition in erectile dysfunctionThe American Journal of Cardiology, 2003
- The Phosphodiesterase 5 Inhibitor Sildenafil Has No Effect on Cerebral Blood Flow or Blood Velocity, but Nevertheless Induces Headache in Healthy SubjectsJournal of Cerebral Blood Flow & Metabolism, 2002
- Pharmacokinetics of sildenafil after single oral doses in healthy male subjects: absolute bioavailability, food effects and dose proportionalityBritish Journal of Clinical Pharmacology, 2002
- Pharmacokinetics and metabolism of sildenafil in mouse, rat, rabbit, dog and manXenobiotica, 1999
- EFFECT OF THE SELECTIVE PHOSPHODIESTERASE TYPE 5 INHIBITOR SILDENAFIL ON ERECTILE FUNCTION IN THE ANESTHETIZED DOGJournal of Urology, 1998
- Sildenafil, a novel effective oral therapy for male erectile dysfunctionBritish Journal of Urology, 1996